- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02134782
Yoga Fatigue Study
A Randomized Controlled Trial of Individualized Yoga to Reduce Fatigue in Hospitalized Children Receiving Intensive Chemotherapy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Fatigue or tiredness is a major problem in children, adolescents and adults receiving intensive chemotherapy for cancer and in those undergoing hematopoietic stem cell transplantation (HSCT). While exercise is good for reducing fatigue, these patients are often too sick to participate in regular exercise sessions. A unique, potentially effective type of exercise is individualized yoga. Yoga is particularly good since it can be tailored to be more or less intensive depending on how the child is feeling. The investigators have previously performed a feasibility study of yoga in children admitted to the hospital receiving very intensive chemotherapy or HSCT and found that our program of yoga is doable. The investigators also found children and their parents like the program.
Preliminary Data: The investigators' team completed a feasibility study of yoga in 11 children with cancer or HSCT recipients meeting similar eligibility criteria as the proposed study. In short, these results demonstrated the feasibility of individualized yoga and suggested several design changes to enhance compliance with outcome ascertainment. The investigators found that the mean ± standard deviation for the baseline and day 21 proxy-report PedsQL MFS general fatigue scores were 46.4±26.8 and 55.6±15.5. These scores are much lower compared to fatigue scores observed in two studies of healthy children in which scores of 88.8±12.3 and 89.3±13.3 were described. This data suggest that fatigue is expected to be very severe in our patient population.
Objectives: Primary: To determine if a 3 week program of individualized yoga for hospitalized children receiving intensive chemotherapy is associated with lower general fatigue or tiredness compared to the control intervention of iPad games, music, movies or books. Secondary: To determine if a 3 week program of yoga is associated with better quality of life and less pain medication use when compared to an iPad activity control program.
Methods: This is a multi-center, randomized trial of individualized yoga for fatigue. Participants are children 8-18 years of age receiving intensive chemotherapy for cancer or undergoing HSCT who are expected to remain in hospital for 3 weeks. Participants will be randomized to individualized yoga or to the iPad activity control program. The intervention is an individualized yoga program in which intensity level may change with each session. The control program consists of visits in which games, music, movies or books on a study-supplied iPad will be offered. Yoga sessions will be offered five times a week over 3 weeks and will be led by a trained yoga teacher. In the control arm, the yoga teacher will visit once a day and will offer children games, music, movies or books on an iPad. Fatigue and quality of life will be measured by the parent at baseline, on day 10 and on day 21. For subjects who remain hospitalized on day 21, they will be offered the alternate arm for one week to promote retention.
The investigators intend to record 20% of yoga and iPad sessions using the iPad to ensure quality control and monitoring of sessions. Recorded files will be downloaded to a secure File Transfer Protocol (FTP) site. Any deviations from the protocol will result in feedback to the site within 1 week of the session and ideally, within 2 days. The research team will also routinely audit the data submitted to ensure completeness of the data submissions.
The investigators plan to enroll 210 subjects at 2 centres in Canada and 1 centre in the United States over 4 years.
Significance: Yoga has the potential to significantly reduce fatigue, a prevalent and distressing symptom, in children with cancer and HSCT. The investigators have assembled the optimal team with the expertise and track record to accomplish this important trial. This trial is an incremental and critically important step in a program of research designed to improve health for children at highest risk for poor quality of life. Results may have broad applicability to other hospitalized pediatric populations and has the potential to change in-hospital care for these patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lillian Sung, MD
- Phone Number: 416-813-5287
- Email: lillian.sung@sickkids.ca
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4V8
- University of Calgary
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X8
- The Hospital for Sick Children
-
-
-
-
Connecticut
-
Hartford, Connecticut, United States, 06106
- Connecticut Children's Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Child diagnosed with any AML, relapsed ALL, stage 3 or 4 Burkitt's or diffuse B large cell lymphoma/leukemia OR about to receive autologous or allogeneic HSCT for any indication
- Child expected to be an inpatient for at least 3 weeks after initiation of chemotherapy or conditioning
- Child aged 8 to 18 years at enrollment. Conditioning regimen may be myeloablative or reduced intensity
Exclusion Criteria:
- Following features present to an extent that would preclude compliance with yoga, as assessed by the attending physician: a) motor disability, b) cognitive disability, c) cardiopulmonary symptoms, or d) known compression fracture resulting in disability
- Parent or patient cannot understand verbal English
- For HSCT patients, planned non-myeloablative conditioning regimen.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Individualized Yoga Intervention Group
Yoga will be administered individually by a trained yoga instructor, and offered daily for 21 days (5 days per week or 15 days in total).
There will be a common structure for all sessions that will include relaxation and breathing exercises.
Additional poses focused on strength, flexibility, and balance will be incorporated at low, moderate or high intensity levels based upon the wishes and abilities of the child and parent and the judgment of the yoga instructor.
The target intensity will be documented and may change with each yoga session.
Each yoga session will vary in duration between 15 and 45 minutes.
Modifications will be made to accommodate devices such as central venous lines, particularly if accessed.
For children who are in isolation, the research team will follow hospital policies and procedures.
|
These children will not receive a study-supplied iPad.
Use of child or hospital supplied iPad games, music, movies or books will be permitted without any modification, encouragement or discouragement of these activities.
There will be no restrictions on concomitant medications.
Standardized sleep hygiene recommendations will be provided.
|
Active Comparator: iPad Activity Control Group
For those randomized to the control group, visits by the same yoga instructors will occur at the same schedule as the yoga intervention.
Contact will be offered daily (5 days per week) for 21 days.
The yoga instructor will offer games, music, movies or books on a study-supplied iPad.
The instructor will offer to interact with the child (for example, read to, or play games with the child) for a maximum of 45 minutes (the maximum length of yoga sessions).
This approach will allow us to control for contact frequency and the individual providing contact, and consequently, to better measure the independent effect of yoga.
These children will not receive yoga during the 3 week iPad activity period; instructors will receive specific training to ensure that no yoga occurs during this time frame.
Use of child or hospital supplied iPad activities will be permitted instead of the study-supplied iPad activities.
|
These children will not receive yoga during the 3 week iPad activity period; instructors will receive specific training to ensure that no yoga occurs during this time frame.
Use of child or hospital supplied iPad activities will be permitted instead of the study-supplied iPad activities.
There will be no restrictions on concomitant medications.
Standardized sleep hygiene recommendations will be provided.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in proxy-reported general fatigue (PedsQL MFS)
Time Frame: Change from baseline to day 10 and day 21
|
The primary outcome is parent/guardian proxy-reported general fatigue using the pediatric population validated questionnaire PedsQL Multidimensional Fatigue Scale (MFS) measured at day 21.
PedsQL MFS assesses general fatigue, sleep/rest fatigue and cognitive fatigue.
The investigators have chosen this fatigue measure as the primary outcome as in our experience, it is sensitive to change and it is easy to administer and complete.
|
Change from baseline to day 10 and day 21
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in proxy-reported other fatigue outcomes (PedsQL MFS)
Time Frame: Change from baseline to day 10 and day 21
|
One of the secondary outcomes is the other fatigue outcomes for proxy-reported PedsQL MFS (sleep/rest fatigue and cognitive fatigue) on days 10 and 21.
|
Change from baseline to day 10 and day 21
|
Change in proxy-reported fatigue outcomes (FS-P)
Time Frame: Change from baseline to day 10 and day 21
|
One of the secondary outcomes is the Fatigue Scale Parent (FS-P) on days 10 and 21.
|
Change from baseline to day 10 and day 21
|
Change in proxy-reported fatigue outcomes (PedsQL Acute Cancer Module)
Time Frame: Change from baseline to day 10 and day 21
|
One of the secondary outcomes is the fatigue outcomes for proxy-reported PedsQL Acute Cancer Module (pain, nausea and anxiety) on days 10 and 21.
|
Change from baseline to day 10 and day 21
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Use of systemic opioids
Time Frame: Change from baseline to day 21
|
All systemic opioid administrations between randomization and date off study will be tabulated and will be expressed as the cumulative amount in morphine equivalents/kg/day on study.
Systemic opioid administration will be obtained from patient's chart review.
Systemic opioid intake is o potential co-variates the could affect fatigue.
|
Change from baseline to day 21
|
Change in self-reported fatigue
Time Frame: Change from baseline to day 10 and day 21
|
Patient self-reported fatigue using the scales PedsQL MFS (Child and adolescent versions) and FS-Adolescent and FS-Child, are exploratory endpoints.
|
Change from baseline to day 10 and day 21
|
Change in self-reported quality of life
Time Frame: Change from baseline to day 10 and day 21
|
Patient self-reported quality of life using the scale PedsQL Acute Cancer Module (child and adolescent version) is another exploratory endpoint.
|
Change from baseline to day 10 and day 21
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Lillian Sung, MD, The Hospital for Sick Children
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Virus Diseases
- Infections
- Immune System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Lymphoproliferative Disorders
- Lymphatic Diseases
- Immunoproliferative Disorders
- Lymphoma, Non-Hodgkin
- DNA Virus Infections
- Tumor Virus Infections
- Leukemia, Lymphoid
- Epstein-Barr Virus Infections
- Herpesviridae Infections
- Lymphoma, B-Cell
- Leukemia, Myeloid
- Lymphoma
- Lymphoma, Large B-Cell, Diffuse
- Fatigue
- Leukemia
- Leukemia, Myeloid, Acute
- Burkitt Lymphoma
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
Other Study ID Numbers
- Yoga RCT
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Myeloid Leukemia (AML)
-
Goethe UniversityCompleted
-
Daiichi Sankyo, Inc.CompletedAMLUnited States, Korea, Republic of, Taiwan, United Kingdom, France, Australia, Spain, Italy, Canada, Singapore, Germany, Netherlands, Hong Kong, Belgium, Croatia, Czechia, Hungary, Poland, Serbia
-
Gemin XCompleted
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingNewly Diagnosed Acute Myeloid Leukemia (AML)China
-
Zhejiang ACEA Pharmaceutical Co. Ltd.Recruiting
-
German Cancer Research CenterUniversity Hospital Heidelberg; University Hospital DresdenNot yet recruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)Germany
-
Georgetown UniversityNational Heart, Lung, and Blood Institute (NHLBI); Jazz PharmaceuticalsRecruitingAcute Myeloid Leukemia (AML) in RemissionUnited States
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
Tarapeutics Science Inc.RecruitingRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
The First Affiliated Hospital of Xiamen UniversityFujian Cancer Hospital; Huizhou Municipal Central Hospital; Chipscreen Biosciences... and other collaboratorsRecruitingLeukemia, Myeloid, Acute | AML Stage, AdultChina
Clinical Trials on Individualized Yoga Intervention Group
-
The Hospital for Sick ChildrenCompleted
-
University of OsloCompletedMental Health | Depression, Anxiety | Sleep Problem | Public Health | University StudentsNorway
-
Hamilton Health Sciences CorporationCompletedPTSDUnited States, Canada
-
University of MinnesotaAgency for Healthcare Research and Quality (AHRQ)Completed
-
Eastern Mediterranean UniversityNot yet recruitingQuality of Life | Health Education | Yoga | Menopause SymptomsCyprus
-
University of California, San FranciscoMount Zion Health Fund; Pritzker Family Foundation; Mental Insight FoundationCompletedDepression, UnipolarUnited States
-
Washington University School of MedicineNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV Infections | Hypertension | HIV Lipodystrophy | HIV Metabolic Cardiovascular Syndrome | HIV Metabolic SyndromesUnited States
-
Colorado State UniversityCompleted
-
Jenilee SneedWithdrawnPsychological Distress | Mindfulness
-
Region Örebro CountyCompletedDepression | Stress | Anxiety